In my original message I was clearly talking about both.... methylated hdrol transdermal being pointless, and how unmethylated hdrol basically too weak to really bother with... (much weaker than oral hdrol and it will have much different action). I brought up EQ/Dbol to show how compounds differ when methylated.
Not sure why you started talking about Boldenone being uninteresting though, but regardless, it's a far more potent AAS, by faaaaaar, even to Tbol, which hdrol is only the prohormone to. Tbol itself is fairly weak, with hdrol being weaker.
If you want to bring an unmethylated hdrol transdermal to market, go for it, but it will be one of the weakest compounds available.